Volume 19, Number 4—April 2013
Serotype IV and Invasive Group B Streptococcus Disease in Neonates, Minnesota, USA, 2000–20101
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: March 15, 2013; Expiration date: March 15, 2014
Upon completion of this activity, participants will be able to:
• Describe the classification of infant group B Streptococcus (GBS) disease and the impact of maternal screening on this illness
• Analyze the epidemiology of infant GBS disease in the current study
• Distinguish the most common GBS genotypes among infants infected in the current study
• Evaluate the significance of GBS genotype IV
Shannon O’Connor, ELS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Shannon O’Connor has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Patricia Ferrieri, MD; Ruth Lynfield, MD; Roberta Creti, PhD; and Aurea Flores have disclosed no relevant financial relationships.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: March 14, 2013
- Page last updated: March 14, 2013
- Page last reviewed: March 14, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)